This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Seoul National University. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Soonsil Hyun: Innovator in Antimicrobial Peptide Research
Introduction
Soonsil Hyun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of antimicrobial peptides, focusing on innovative solutions to combat gram-negative bacteria. With a total of 2 patents, his work is paving the way for advancements in medical and pharmaceutical applications.
Latest Patents
Hyun's latest patents include two groundbreaking inventions. The first patent is titled "Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof." This invention relates to a broken or kinked helical peptide or peptide analogue that penetrates the membranes of gram-negative bacteria, offering potential for new antimicrobial compositions. The second patent is "Cell penetrating stapled peptide, manufacturing method therefor, and use thereof." This invention focuses on an amphipathic alpha-helical stapled peptide designed for intracellular delivery of active substances, enhancing the effectiveness of therapeutic agents.
Career Highlights
Soonsil Hyun is affiliated with Seoul National University, where he conducts research and develops innovative solutions in the field of peptide technology. His work has garnered attention for its potential applications in treating bacterial infections, particularly those caused by resistant strains.
Collaborations
Hyun collaborates with notable colleagues, including Jaehoon Yu and Yan Lee, who contribute to his research endeavors. Their combined expertise enhances the development of new antimicrobial strategies and technologies.
Conclusion
Soonsil Hyun's contributions to antimicrobial peptide research are significant and impactful. His innovative patents reflect a commitment to addressing critical challenges in healthcare. The advancements he is making in this field hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
